Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents

Journal of Medicinal Chemistry

Volumn 49, Issue 17, 2006, Pages 5372-5376

  Pirali, Tracey ^a   Busacca, Sara ^a   Beltrami, Lorena ^a   Imovilli, Daniela ^a   Pagliai, Francesca ^a   Miglio, Gianluca ^a   Massarotti, Alberto ^a   Verotta, Luisella ^b   Tron, Gian Cesare ^a   Sorba, Giovanni ^a   Genazzani, Armando A ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHOXYPHENYL) 4 (3,4,5 TRIMETHOXYPHENYL)FURAN; ANTINEOPLASTIC AGENT; COMBRETAFURAN DERIVATIVE; COMBRETASTATIN A4; FURAN DERIVATIVE; UNCLASSIFIED DRUG;

ALDOL REACTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; EVALUATION; MICROTUBULE ASSEMBLY; NEUROBLASTOMA; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANISOLES; ANTINEOPLASTIC AGENTS; BIBENZYLS; CELL DEATH; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FURANS; HUMANS; MOLECULAR STRUCTURE; NEUROBLASTOMA; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN;

EID: 33747514168     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060621o     Document Type: Article

References (26)

1. Neri, D.; Bicknell, R. Tumor vascular targeting. Nat. Rev. Cancer 2005, 5, 436-446.
2. Jordan, M. A.; Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 2004, 4, 253-265.
3. Young, S. L.; Chaplin, D. J. Combretastatin A4 phosphate: background and current clinical status. Expert Opin. Invest. Drugs 2004, 13, 1171-1182.
4. Pettit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.; et al. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia 1989, 45. 209-211.
5. Tron, G. C.; Pirali, T.; Sorba, G.; Pagliai, F.; Busacca, S.; Genazzani, A. A. Medicinal chemistry of combretastatin A4: present and future directions. J. Med. Chem. 2006, 49, 3033-3044.
6. Nam, N. H. Combretastatin A-4 analogues as antimitotic antitumor agents. Curr. Med. Chem. 2003, 10, 1697-1722.
7. Tron, G. C.; Pagliai, F.; Del Grosso, E.; Genazzani, A. A.; Sorba, G. Synthesis and cytotoxic evaluation of combretafurazans. J. Med. Chem. 2005, 48, 3260-3268.
8. Pedley, R. B.; Hill, S. A.; Boxer, G. M.; Flynn, A. A.; Boden, R.; et al. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate. Cancer Res. 2001, 61, 4716-4722.
9. Chaplin, D. J.; Hill, S. A. The development of combretastatin A4 phosphate as a vascular targeting agent. Int. J. Radiat. Oncol. Biol., Phys. 2002, 54, 1491-1496.
10. Dikshit, D. K.; Singh, S.; Singh, M. M.; Kamboj, V. P. Synthesis and biological activity of 2,3- and 3,4-diarylfurans and 2,3,4-triaryl-2,5- dihydrofurans. Indian J. Chem. 1990, B29, 954-960.
11. Kim, Y.; Nam, N. H.; You, Y. J.; Ahn, B. Z. Synthesis and cytotoxicity of 3,4-diaryl-2(5H)-furanones. Bioorg. Med. Chem. Lett. 2002, 12, 719-722.
12. Rahim, M. A.; Rao, P. N. P.; Knaus, E. E. Isomeric acetoxy analogues of rofecoxib: a novel class of highly potent and selective cyclooxy-genase-2 inhibitors. Bioorg. Med. Chem. Lett. 2002, 12, 2753-2756.
13. Padakanti, S.; Veeramaneni, V. R.; Pattabiraman, V. R.; Pal, M.; Yeleswarapu, K. R. A simple and rapid entry to 5-alkyl (aryl)-5-hydroxy-3,4- diarylfuranones and 3a-hydroxy-1-aryl-2,3a,4,5-tetrahydronaphthofuranones via a tandem esterification and oxidative cyclization process. Tetrahedron Lett. 2002, 43, 8715-8719.
14. Pattabiraman, V. R.; Padakanti, S.; Veeramaneni, V. R.; Pal, M.; Yeleswarapu, K. R. Synthesis of 3,4-diaryl-substituted maleic anhydride/maleimide via unusual oxidative cyclization of phenacyl ester/amide. Synlett 2002, 947-951.
15. Habeeb, A. G.; Rao, P. N. P.; Knaus, E. E. Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere. J. Med. Chem. 2001, 44, 3039-3042.
16. Padwa, A.; Dehem, D. A facile one-step synthesis of 3,5,5-trisubstituited 2(5H)-furanones. J. Org. Chem. 1975, 40, 3139-3141.
17. Gopidas, K. R.; Lohray, B. B.; Rajadurai, S.; Das, P. K.; George, M. V. Sensitized photorearrangement of 3,3,5-triaryl-2(3H)-furanones to 3,4,5-triaryl-2(5H)-furanones. Steady-state and laser flash photolysis investigations. J. Org. Chem. 1987, 52, 2831-2838.
18. Minato, H.; Nagasaki, T. A new synthetic method for furan compounds. Chem. and Ind. 1965, 21, 899-900.
19. Minato, H.; Nagasaki, T. A new method for the synthesis of furan compounds. J. Chem. Soc. 1966, 4, 377-379.
20. Kratz, F.; Beyer, U.; Schuette, M. T. Drug-polymer conjugates containing acid-cleavable bonds. Crit. Rev. Ther. Drug Carrier Syst. 1999, 16, 245-288.
21. Prinz, H.; Ishii, Y.; Hirano, T.; Stoiber, T.; Camacho Gomez, J. A.; et al. Novel benzylidene-9-(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. J. Med. Chem. 2003, 46, 3382-3394.
22. Coggiola, B.; Pagliai, F.; Allegrone, G.; Genazzani, A. A.; Tron, G. C. Synthesis and biological activity of mustard derivatives of combretastatins. Bioorg. Med. Chem. Lett. 2005, 15, 3551-3554.
23. Antunes, H.; Fardelone, L. C.; Rodrigues, A. R.; Moran, P. J. S. Chemoenzymatic syntheses of (R)-2-bromo-, (R)-2-chloro- and (R)-2-azido-1-(1,3- benzodioxol-5-yl)-1-ethanol. Tetrahedron: Asymmetry 2004, 2615-2620.
24. Brossi, A.; Gurien, H.; Rachlin, A. I.; Teitel, S. Selective demethylation of 3,4-dimethoxy-substituited aromatic aldehydes and ketones. J. Org. Chem. 1967, 32, 1269-1270.
25. Pratesi, P.; Lamanna, A.; Villa, L.; Grana, E.; Lilla, L. Struttura chimica e attività biologica delle catecolamine (Chemical structure and biological activity of the catecholamines). Farmaco, Ed. Sci. 1963, 18, 920-931.
26. Chen, Q.; Sowa, D. A.; Cai, J.; Gabathuler, R. Synthesis of doxorubicin conjugates through hydrazone bonds to melanotransferrin P97. Synth. Commun. 2003, 33, 2377-2390.